» Articles » PMID: 33609602

Bone Marrow Mesenchymal Stem Cell-derived Exosomal MicroRNA-125a Promotes M2 Macrophage Polarization in Spinal Cord Injury by Downregulating IRF5

Overview
Journal Brain Res Bull
Specialty Neurology
Date 2021 Feb 20
PMID 33609602
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Spinal cord injury (SCI) may cause loss of locomotor function, and macrophage is a major cell type in response to SCI with M1- and M2-phenotypes. The protective role of bone marrow mesenchymal stem cells (BMMSC)-derived exosomes (B-Exo) in SCI has been underscored, while their regulation on M2 macrophage polarization and the mechanism remain to be clarified.

Methods: A rat model of SCI was developed and treated with extracted B-Exo. Recovery of motor function was assessed by Basso-Beattie-Bresnahan (BBB) score. The apoptosis and degeneration of neurons, and macrophage polarization were evaluated. Subsequently, genes differentially expressed in the rat spinal cord after B-Exo treatment were analyzed. Later, the relationships between B-Exo and interferon regulatory factor 5 (IRF5) or macrophage polarization were clarified. Later, the upstream microRNAs (miRNAs) of IRF5 were validated by bioinformatics prediction and dual-luciferase experiments. Finally, the role of miR-125a in the neuroprotection of SCI was verified by rescue experiments.

Results: B-Exo promoted the recovery of locomotor function and M2-phenotype polarization, whereas inhibited neuronal apoptosis and degeneration and the inflammatory response caused by SCI in rats. In addition, IRF5 expression was reduced after B-Exo treatment. IRF5 promoted macrophage polarization towards M1-phenotype and secretion of inflammatory factors. There is a binding relationship between miR-125a and IRF5. Knockdown of miR-125a in B-Exo increased IRF5 expression in spinal cord tissues of SCI rats and attenuated the neuroprotective effect of B-Exo against SCI.

Conclusion: Exosomal miR-125a derived from BMMSC exerts neuroprotective effects by targeting and negatively regulating IRF5 expression in SCI rats.

Citing Articles

Stem cell-derived exosome treatment for acute spinal cord injury: a systematic review and meta-analysis based on preclinical evidence.

Mou C, Xia Z, Wang X, Dai X, Wang J, Zhang C Front Neurol. 2025; 16:1447414.

PMID: 39926016 PMC: 11802430. DOI: 10.3389/fneur.2025.1447414.


The role of natural products targeting macrophage polarization in sepsis-induced lung injury.

Li Y, Ai S, Li Y, Ye W, Li R, Xu X Chin Med. 2025; 20(1):19.

PMID: 39910395 PMC: 11800549. DOI: 10.1186/s13020-025-01067-4.


Characterizing the pan-cancer role of exosomal miRNAs in metastasis across cancers.

Agrawal P, Olgun G, Singh A, Gopalan V, Hannenhalli S Comput Struct Biotechnol J. 2025; 27:252-264.

PMID: 39866667 PMC: 11763893. DOI: 10.1016/j.csbj.2024.12.025.


Stem Cell-Derived Extracellular Vesicle-Mediated Therapeutic Signaling in Spinal Cord Injury.

Poongodi R, Hsu Y, Yang T, Huang Y, Yang K, Lin H Int J Mol Sci. 2025; 26(2).

PMID: 39859437 PMC: 11765593. DOI: 10.3390/ijms26020723.


Exosomal MiRNA Therapy for Central Nervous System Injury Diseases.

Chang C, Weiping L, Jibing C Cell Mol Neurobiol. 2024; 45(1):3.

PMID: 39652146 PMC: 11628439. DOI: 10.1007/s10571-024-01522-0.